Cover Image
市場調查報告書

Beech Tree Labs, Inc.:產品平台分析

Beech Tree Labs, Inc. - Product Pipeline Review - 2014

出版商 Global Markets Direct 商品編碼 214151
出版日期 內容資訊 英文 33 Pages
訂單完成後即時交付
價格
Back to Top
Beech Tree Labs, Inc.:產品平台分析 Beech Tree Labs, Inc. - Product Pipeline Review - 2014
出版日期: 2014年05月30日 內容資訊: 英文 33 Pages
簡介

Beech Tree Labs, Inc.ha是從事慢性疾病用醫藥品的藥物研究、開發之製藥企業。

本報告提供Beech Tree Labs, Inc.的治療藥開發平台現狀及各開發階段的比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥的評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

Beech Tree Labs, Inc.的基本資料

Beech Tree Labs, Inc.概要

  • 主要資訊
  • 企業資料

Beech Tree Labs, Inc.:R&D概要

  • 主要的治療範圍

Beech Tree Labs, Inc.:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

Beech Tree Labs, Inc.:開發中產品概況

  • 臨床實驗階段的開發中產品
    • 第二階段的產品/聯合治療模式
    • 第一階段的產品/聯合治療模式
  • 初期階段產品開發中產品
    • 前臨床階段的產品/聯合治療模式

Beech Tree Labs, Inc.:開發階段不明的開發中產品

  • 開發階段不明的產品/聯合治療模式

Beech Tree Labs, Inc.:藥物簡介

  • BTL-na
  • BTL-TML-HSV
  • BTL-ui
  • 慢性前列腺炎用的醫藥品
  • BTL-TML001
  • BTL-ng
  • BTL-slo
  • 慢性便秘用的醫藥品
  • 神經病變用的醫藥品
  • 心肌病用的醫藥品

Beech Tree Labs, Inc.:開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Beech Tree Labs, Inc.:最近的開發平台趨勢

Beech Tree Labs, Inc.:總公司和子公司的所地

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC04910CDB

Global Markets Direct's, 'Beech Tree Labs, Inc. - Product Pipeline Review - 2014', provides an overview of the Beech Tree Labs, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Beech Tree Labs, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Beech Tree Labs, Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Beech Tree Labs, Inc.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Beech Tree Labs, Inc.'s pipeline products

Reasons to buy

  • Evaluate Beech Tree Labs, Inc.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Beech Tree Labs, Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Beech Tree Labs, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Beech Tree Labs, Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Beech Tree Labs, Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Beech Tree Labs, Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Beech Tree Labs, Inc. Snapshot
    • Beech Tree Labs, Inc. Overview
    • Key Information
    • Key Facts
  • Beech Tree Labs, Inc. - Research and Development Overview
    • Key Therapeutic Areas
  • Beech Tree Labs, Inc. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Beech Tree Labs, Inc. - Pipeline Products Glance
    • Beech Tree Labs, Inc. - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
      • Phase I Products/Combination Treatment Modalities
    • Beech Tree Labs, Inc. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
    • Beech Tree Labs, Inc. - Unknown Stage Pipeline Products
      • Unknown Products/Combination Treatment Modalities
  • Beech Tree Labs, Inc. - Drug Profiles
    • BTL-na
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • BTL-TML-HSV
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • BTL-ui
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Drug for Chronic Prostatitis
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • BTL-TML001
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • BTL-ng
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • BTL-slo
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Drug For Chronic Constipation
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Drug for Neuropathy
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Drug for Cardiomyopathy
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Beech Tree Labs, Inc. - Pipeline Analysis
    • Beech Tree Labs, Inc. - Pipeline Products by Target
    • Beech Tree Labs, Inc. - Pipeline Products by Route of Administration
    • Beech Tree Labs, Inc. - Pipeline Products by Molecule Type
    • Beech Tree Labs, Inc. - Pipeline Products by Mechanism of Action
  • Beech Tree Labs, Inc. - Recent Pipeline Updates
  • Beech Tree Labs, Inc. - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Beech Tree Labs, Inc., Key Information
  • Beech Tree Labs, Inc., Key Facts
  • Beech Tree Labs, Inc. - Pipeline by Indication, 2014
  • Beech Tree Labs, Inc. - Pipeline by Stage of Development, 2014
  • Beech Tree Labs, Inc. - Monotherapy Products in Pipeline, 2014
  • Beech Tree Labs, Inc. - Phase II, 2014
  • Beech Tree Labs, Inc. - Phase I, 2014
  • Beech Tree Labs, Inc. - Preclinical, 2014
  • Beech Tree Labs, Inc. - Unknown, 2014
  • Beech Tree Labs, Inc. - Pipeline by Target, 2014
  • Beech Tree Labs, Inc. - Pipeline by Route of Administration, 2014
  • Beech Tree Labs, Inc. - Pipeline by Molecule Type, 2014
  • Beech Tree Labs, Inc. - Pipeline Products by Mechanism of Action, 2014
  • Beech Tree Labs, Inc. - Recent Pipeline Updates, 2014
  • Beech Tree Labs, Inc., Other Locations

List of Figures

  • Beech Tree Labs, Inc. - Pipeline by Top 10 Indication, 2014
  • Beech Tree Labs, Inc. - Pipeline by Stage of Development, 2014
  • Beech Tree Labs, Inc. - Monotherapy Products in Pipeline, 2014
  • Beech Tree Labs, Inc. - Pipeline by Top 10 Route of Administration, 2014
  • Beech Tree Labs, Inc. - Pipeline by Top 10 Molecule Type, 2014
Back to Top